The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia.
Chie IshikawaNaoki MoriPublished in: European journal of haematology (2020)
CUDC-907 may be a potential therapeutic agent for ATL.